Lockheed Martin 10-Qquarter ended 2026-09-27

Executive Summary

Lockheed Martin sells military aircraft, missiles and defense systems to governments, earning revenue through production and support contracts. It is expanding missile-defense capacity and F-35 production and sustainment, supported by a $52.5B multiyear PAC-3 MSE award. Q3 sales grew 11%, led by missiles and aircraft, but operating margins narrowed as production growth did not translate proportionately into profit. The opportunity is converting a $292B backlog into deliveries and cash; the threat is that capacity constraints, funding delays and fixed-price overruns erode its value.

What's Happening in the Business

• Missile production expansion: Multiyear agreements cover higher quantities and faster deliveries of PAC-3 MSE and THAAD missile-defense systems, alongside accelerated PrSM and JATM production. Lockheed is working with suppliers and government customers to expand capacity; long production cycles mean orders will not immediately become revenue.
• F-35 and aircraft growth: Higher F-35 production and sustainment activity supported Aeronautics, alongside recognition of previously incurred C-130 pre-contract costs. Lockheed delivered 43 F-35s during Q3 and had 274 aircraft in backlog, but negotiations on production lots 20 and higher remain unfinished.
• Maritime acquisition: Lockheed agreed to buy Ultra Maritime Solutions for $3.45B in cash, with closing expected in Q4 2026. The transaction expands its maritime operations and creates integration demands while production capacity also requires investment.

Key Financial Highlights

• Margins: Consolidated Q3 operating margin declined to 11.8% from 12.3%. Aeronautics and Space margins fell, while missile margins were broadly stable.
• Contract-estimate effects: Nine-month profit-booking adjustments added $965M to segment profit vs a $200M reduction last year. These revisions to estimated contract profitability explain much of the earnings improvement; current-period unfavorable adjustments still included F-16, C-130, Heavy Lift and Seahawk.
• Cash conversion: Nine-month operating cash flow exceeded net earnings, with deferred taxes contributing $1.11B, while contract assets absorbed $3.90B. After $1.27B of capital expenditures, free cash flow was $5.63B, up 35%; collections and tax timing matter alongside earnings.
• Taxes and refunds: The nine-month effective tax rate fell to 15.6% from 16.4%, mainly from increased deductions on foreign-derived income. Lockheed also received ≈$225M of tariff refunds, a cash benefit distinct from production growth.
• Capital allocation: No shares were repurchased; outstanding shares rose from ≈229M to ≈230M. Dividends consumed $2.41B, and the pending acquisition will use cash on hand, which stood at $5.96B.

Risk Assessment

• Fixed-price execution: Classified Aeronautics and missile programs have accumulated losses of ≈$1.8B and ≈$1.5B, respectively; further overruns could require additional charges, including on remaining loss-making missile-program options.
• Government funding and F-35 authorization: The U.S. Government supplied 70% of nine-month sales, while interim funding runs through 12/11/2026; F-35 lot 20 advance-acquisition costs already exceed authorization and funding, exposing cash recovery and schedules.
• Capacity constraints: Supplier shortages, workforce constraints and rare-earth availability could prevent higher missile and aircraft orders from becoming profitable deliveries.
• Canadian helicopter recovery: The Canadian Maritime Helicopter Program carries $565M of contract assets after ≈$670M of cumulative losses; unsuccessful restructuring discussions could undermine recovery.
• Launch-venture support: Lockheed guarantees $750M of United Launch Alliance borrowings and expects further support; Vulcan Centaur performance problems could trigger additional funding or investment losses.

This 10-Q lists no risk factors of its own and refers to the annual report. The risks above come from the rest of this filing. Full list: the company's 10-Ks on SEC.

What to Watch

• Missile ramp: The PAC-3 MSE award drove the backlog increase. Subsequent filings should show higher missile deliveries and sales without margin erosion; delays or charges would signal capacity is lagging commitments.
• F-35 funding: The aircraft represented ≈27% of sales. Additional lot 20 authorization and finalized contracts would support continued production; unresolved funding could increase cash tied up in work.
• Ultra Maritime integration: The cash-funded acquisition is expected to close in Q4 2026. Later filings should show retained customers and operating contributions rather than disruption or impairment.
• Profit quality and collections: Favorable contract revisions and tax timing supported nine-month results. Sustained earnings with fewer adverse revisions and better contract-asset collections would strengthen the recovery; renewed losses or delayed receipts would weaken it.